The massive volume surge over the past 10 days of 180 million shares traded is easily BCRX's highest ever.
Volume Precedes Price.
The company & its COVID-19 candidate Gildesivir continue to fly under the national media radar but for how long? The big Tutes have found BCRX especially Bakers Bros & BlackRock. BoA just bought 276k, Bank of NY Mellon 109k.
"What's the BCRX price target?" estimates are all over the map. Soon to be commercialized Berotralstat has a bullish $500M revenue projection. And then there's Galidesivir with its Dr Fauci, NIAID, BARDA, NIH, US Army & DOD connections.
The need NOW is a therapeutic to combat COVID-19 that can be orally administered, mass produced expeditiously & gives confidence if infected by COVID-19 that there's a medicine available to save us. Then we can return to the new normalcy & restart the world's economy. Galidesivir might soon be on the COVID-19 front lines.
Market Data 
Markets 
AI
